Your browser doesn't support javascript.
loading
Correction to: Clinical Investigation on Endogenous Biomarkers to Predict Strong OAT-Mediated Drug-Drug Interactions.
Willemin, Marie-Emilie; Van Der Made, Thomas K; Pijpers, Ils; Dillen, Lieve; Kunze, Annett; Jonkers, Sophie; Steemans, Kathleen; Tuytelaars, An; Jacobs, Frank; Monshouwer, Mario; Scotcher, Daniel; Rostami-Hodjegan, Amin; Galetin, Aleksandra; Snoeys, Jan.
Affiliation
  • Willemin ME; Drug Metabolism and Pharmacokinetics, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340, Beerse, Belgium. mwille15@its.jnj.com.
  • Van Der Made TK; Centre for Applied Pharmacokinetic Research, School of Health Sciences, Division of Pharmacy and Optometry, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Pijpers I; Drug Metabolism and Pharmacokinetics, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340, Beerse, Belgium.
  • Dillen L; Drug Metabolism and Pharmacokinetics, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340, Beerse, Belgium.
  • Kunze A; Drug Metabolism and Pharmacokinetics, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340, Beerse, Belgium.
  • Jonkers S; Drug Metabolism and Pharmacokinetics, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340, Beerse, Belgium.
  • Steemans K; Drug Metabolism and Pharmacokinetics, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340, Beerse, Belgium.
  • Tuytelaars A; Drug Metabolism and Pharmacokinetics, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340, Beerse, Belgium.
  • Jacobs F; Drug Metabolism and Pharmacokinetics, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340, Beerse, Belgium.
  • Monshouwer M; Drug Metabolism and Pharmacokinetics, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340, Beerse, Belgium.
  • Scotcher D; Centre for Applied Pharmacokinetic Research, School of Health Sciences, Division of Pharmacy and Optometry, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Rostami-Hodjegan A; Centre for Applied Pharmacokinetic Research, School of Health Sciences, Division of Pharmacy and Optometry, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Galetin A; Centre for Applied Pharmacokinetic Research, School of Health Sciences, Division of Pharmacy and Optometry, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Snoeys J; Drug Metabolism and Pharmacokinetics, Janssen Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340, Beerse, Belgium.
Clin Pharmacokinet ; 61(3): 463, 2022 Mar.
Article in En | MEDLINE | ID: mdl-35175504
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Clin Pharmacokinet Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Clin Pharmacokinet Year: 2022 Document type: Article Affiliation country: